col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

97 Results       Page 1

Wiley: Clinical and Translational Medicine
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―12 From intestinal metabolites to the brain: Investigating the mysteries of Long COVID Shan Liu, Ashwarya S. Devason, Maayan Levy
2 [GO] 2024―Feb―15 A Chinese herbal formula Kesuting Syrup against COVID-19: Leveraging multidimensional computations in network pharmacology-driven experimental and clinical trials Cheng Zhang, Tian-Tian Sun, Ying Lv, Xing Li, Yun Ling, Ning Wang, et al. (+3)
3 [GO] 2024―Jan―27 Letter to the Editor with # CTM2-2023-10-2488 entitled ‘Antibody responses as correlates of protection against SARS-CoV-2 in the Omicron era: A 5-month prospective cohort study in Korean healthcare workers’ So Yun Lim, Jineui Kim, Ji-Soo Kwon, Sung-Woon Kang, Seung-Beom Kim, Woori Kim, et al. (+19)
4 [GO] 2024―Jan―15 The roles of innate and adaptive immunity in inactivated viral vaccination-mediated protection against COVID-19 Shanhe Yu, Shijun Chen, Jiang Zhu, Jieming Qu
5 [GO] 2023―Dec―14 Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, et al. (+24)
6 [GO] 2023―Dec―08 Learning from the past? How biased memories of the pandemic endanger preparation for future crises Philipp Sprengholz, Luca Henkel, Robert Böhm, Cornelia Betsch
7 [GO] 2023―Nov―10 Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsis Hu Meng, Arjun Sengupta, Emanuela Ricciotti, Antonijo Mrčela, Divij Mathew, Liudmila L. Mazaleuskaya, et al. (+16)
8 [GO] 2023―Nov―06 Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing Euijin Chang, Jungmin Lee, Jun-Won Kim, Jong Hyeon Seok, Joon-Yong Bae, Jeonghun Kim, et al. (+10)
9 [GO] 2023―Oct―30 Polymerised type I collagen modifies the physiological network of post-acute sequelae of COVID-19 depending on sex: a randomised clinical trial Janette Furuzawa-Carballeda, Paola Vanessa Olguín-Rodríguez, Gonzalo Torres-Villalobos, Antonio Barajas-Martínez, Vania Jocelyn Martínez-Garcés, Ruben Fossion, et al. (+10)
10 [GO] 2023―Sep―11 COVID-19 vaccine hesitancy of older people in China Gewei Wang, Yao Yao, Yafeng Wang, Jinquan Gong, Qinqin Meng, Hui Wang, et al. (+3)
11 [GO] 2023―Aug―24 Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study Suad Hannawi, Rong-Rong Zhang, Alaa Abuquta, Linda Safeldin, Aala Hassan, Ahmad Alamadi, et al. (+12)
12 [GO] 2023―Jun―08 Development and validation of a novel CD4+ T cell-related gene signature to detect severe COVID-19 Da-Wei Zhang, Fang Li, Yuan-Yuan Wei, Lei Hu, Su-Hong Chen, Ming-Ming Yang, et al. (+2)
13 [GO] 2023―Jan―20 Heterogenous antibody and T-cell responses to SARS-CoV-2 mRNA vaccines among immunocompromised young people Liangjian Lu, Chang Yien Chan, Pauline P. L. Chan-Ng, Mya Than, Pamela S. Y. Tan, Lee Kean Lim, et al. (+9)
14 [GO] 2023―Jan―19 Evaluation of vaccine effectiveness against SARS-CoV-2 variants by serological epitope profiling Cheng Li, Zhenlin Yang, Yanling Wu, Tianlei Ying
15 [GO] 2023―Jan―14 Impacts of delta and omicron variants on inactivated SARS-CoV-2 vaccine-induced T cell responses in patients with autoimmune diseases and healthy controls Shuyi Wang, Jin Li, Shuang Wang, Yujin Ye, Mengyuan Li, Yihao Liu, et al. (+8)
16 [GO] 2023―Jan―07 Transcriptomic analysis for the retested positive COVID-19 patients with long-term persistent SARS-CoV-2 but without symptoms in Wuhan Cuidan Li, Liya Yue, Yingjiao Ju, Jie Wang, Hao Lu, Lin Li, et al. (+11)
17 [GO] 2022―Dec―20 Raman spectroscopic cellomics for the detection of SARS-CoV-2-associated neutrophil activation after TNF-α stimulation Aikaterini Pistiki, Franziska Hornung, Anja Silge, Anuradha Ramoji, Oleg Ryabchykov, Thomas W. Bocklitz, et al. (+4)
18 [GO] 2022―Nov―30 Elevated ubiquitination contributes to protective immunity against severe SARS-CoV-2 infection Yinggang Che, Dongbo Jiang, Yong Zhang, Junqi Zhang, Tianqi Xu, Yuanjie Sun, et al. (+11)
19 [GO] 2022―Nov―17 When the clock ticks wrong with COVID-19 Silvana Papagerakis, Raed Said, Farinaz Ketabat, Razi Mahmood, Meenakshi Pundir, Liubov Lobanova, et al. (+7)
20 [GO] 2022―Nov―07 Comprehensive profiling of the human viral exposome in households containing an at-risk child with mitochondrial disease during the 2020-2021 COVID-19 pandemic Eliza M. Gordon-Lipkin, Christopher S. Marcum, Shannon Kruk, Elizabeth Thompson, Sophie E. M. Kelly, Heather Kalish, et al. (+4)
21 [GO] 2022―Nov―02 RNASeq profiling of COVID19-infected patients identified an EIF2AK2 inhibitor as a potent SARS-CoV-2 antiviral Sidharth Jain, Samantha Rego, Steven Park, Yiran Liu, Simone Parn, Kush Savsani, et al. (+2)
22 [GO] 2022―Oct―14 On the essentiality of the angiotensin converting enzyme 2 receptor for SARS-CoV-2 infection and the potential of soluble angiotensin converting enzyme 2 proteins as universal approach for variants causing COVID-19 Luise Hassler, Josef Penninger, Daniel Batlle
23 [GO] 2022―Oct―10 Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19 Makoto Kurano, Koh Okamoto, Daisuke Jubishi, Hideki Hashimoto, Eri Sakai, Daisuke Saigusa, et al. (+7)
24 [GO] 2022―Oct―07 Single-cell co-expression analysis using computational machine learning reveals oxidative, immunopathologic, and myocardial responses for multi-organ failure in COVID-19 Cheng Zhang, Ning Wang, Guoming Chen, Guoyi Tang, Chiwing Tam, Hor-Yue Tan, et al. (+2)
25 [GO] 2022―Sep―19 Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: A single-blind randomized controlled trial Hildur Arnardottir, Sven-Christian Pawelzik, Philip Sarajlic, Alessandro Quaranta, Johan Kolmert, Dorota Religa, et al. (+2)
26 [GO] 2022―Sep―14 Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity Tianyu Cao, Li Liu, Kelvin Kai-Wang To, Chun-Yu Lim, Runhong Zhou, Yue Ming, et al. (+19)
27 [GO] 2022―Sep―14 A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults Deyan Luo, Hongxing Pan, Peng He, Xiaolan Yang, Tao Li, Nianzhi Ning, et al. (+21)
28 [GO] 2022―Aug―21 Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections Murad Alahdal, Eyad Elkord
29 [GO] 2022―Jul―22 The impact of ACE2 and co-factors on SARS-CoV-2 infection in colorectal cancer Shuwei Li, Silu Chen, Qiuyuan Zhu, Shuai Ben, Fang Gao, Junyi Xin, et al. (+5)
30 [GO] 2022―Jul―15 Inhibition of the lectin pathway of complement ameliorates hypocomplementemia and restores serum bactericidal activity in patients with severe COVID-19 Nicholas J. Lynch, Andrew C. Y. Chan, Youssif M. Ali, Priyanka Khatri, Ifeoluwa E. Bamigbola, Gregory Demopulos, et al. (+3)
31 [GO] 2022―Jul―15 Integrating plasma cell-free DNA with clinical laboratory results enhances the prediction of critically ill patients with COVID-19 at hospital admission Yong Bai, Fang Zheng, Tongda Zhang, Qiuhong Luo, Yuxue Luo, Ruilong Zhou, et al. (+12)
32 [GO] 2022―Jul―09 LncRNAs harbouring regulatory motifs within repeat elements modulate immune response towards COVID-19 disease severity and clinical outcomes Partha Chattopadhyay, Pallavi Mishra, Kriti Khare, Aanchal Yadav, Priyanka Mehta, Sheeba Saifi, et al. (+10)
33 [GO] 2022―Jul―09 Profiling of host entry factors in adults and fetuses for severe acute respiratory syndrome coronavirus-2 infection indicates its developmental regulation Shizhe Yu, Haoren Wang, Lin Zhang, Qiang Cai, Duo Ma, Jian Zhao, et al. (+3)
34 [GO] 2022―Jul―09 Antigenic imprinting in SARS-CoV-2 S. Momsen Reincke, Harald Prüss, Ian A. Wilson, Jakob Kreye
35 [GO] 2022―Jun―13 Human-host transcriptomic analysis reveals unique early innate immune responses in different sub-phenotypes of COVID-19 Ranjeet Maurya, Uzma Shamim, Partha Chattopadhyay, Priyanka Mehta, Pallavi Mishra, Priti Devi, et al. (+14)
36 [GO] 2022―Jun―13 Altered microRNA expression in severe COVID-19: Potential prognostic and pathophysiological role Nathalie Garnier, Kato Pollet, Marie Fourcot, Morgan Caplan, Guillemette Marot, Julien Goutay, et al. (+7)
37 [GO] 2022―Jun―13 Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence Zhongtian Qi, Jianbo Wu, Shibo Jiang
38 [GO] 2022―Jun―09 Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS-CoV-2 vaccine Xingli Xu, Yun Liao, Guorun Jiang, Weiguo Yao, Suqin Duan, Kang Xiao, et al. (+31)
39 [GO] 2022―May―11 Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational study Roberto Lozano-Rodríguez, Verónica Terrón-Arcos, Karla Montalbán-Hernández, José Carlos Casalvilla-Dueñas, Marta Bergón-Gutierrez, Alejandro Pascual-Iglesias, et al. (+18)
40 [GO] 2022―May―11 Pathogenicity of SARS-CoV-2 Omicron Hin Chu, Kwok-Yung Yuen
41 [GO] 2022―May―11 Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS María C. García-Hidalgo, Jessica González, Iván D. Benítez, Paola Carmona, Sally Santisteve, Anna Moncusí-Moix, et al. (+21)
42 [GO] 2022―Apr―22 Breakthrough infections and waning immune responses with ChAdOx1 nCoV-19 or mRNA vaccine in healthcare workers So Yun Lim, Jiwon Jung, Ji Yeun Kim, Soonju Park, Ji-Soo Kwon, So Yeon Park, et al. (+14)
43 [GO] 2022―Apr―13 Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response Alberto Pérez-Gómez, Carmen Gasca-Capote, Joana Vitallé, Francisco J. Ostos, Ana Serna-Gallego, María Trujillo-Rodríguez, et al. (+19)
44 [GO] 2022―Apr―07 PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron Arpan Acharya, Anup S. Pathania, Kabita Pandey, Michellie Thurman, Kendra R. Vann, Tatiana G. Kutateladze, et al. (+3)
45 [GO] 2022―Mar―17 Effect of polymerised type I collagen on hyperinflammation of adult outpatients with symptomatic COVID-19 Silvia Méndez-Flores, Ángel Priego-Ranero, Daniel Azamar-Llamas, Héctor Olvera-Prado, Kenia Ilian Rivas-Redonda, Eric Ochoa-Hein, et al. (+12)
46 [GO] 2022―Feb―27 Potent antibody immunity to SARS-CoV-2 variants elicited by a third dose of inactivated vaccine Bin Ju, Bing Zhou, Shuo Song, Qing Fan, Xiangyang Ge, Haiyan Wang, et al. (+5)
47 [GO] 2022―Feb―20 Zinc and vitamin C intake increases spike and neutralising antibody production following SARS-CoV-2 infection Amy May Lin Quek, Delicia Shu Qin Ooi, Ooiean Teng, Chang Yien Chan, Geelyn Jeng Lin Ng, Mei Yen Ng, et al. (+8)
48 [GO] 2022―Jan―27 T FH 2 cells associate with enhanced humoral immunity to SARS-CoV-2 inactivated vaccine in patients with allergic rhinitis Yin Yao, Zhe-Zheng Wang, Ao Huang, Yan Liu, Nan Wang, Zhi-Chao Wang, et al. (+7)
49 [GO] 2022―Jan―27 Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses Runhong Zhou, Kelvin Kai-Wang To, Qiaoli Peng, Jacky Man-Chun Chan, Haode Huang, Dawei Yang, et al. (+8)
50 [GO] 2022―Jan―25 COVID-19 bimodal clinical and pathological phenotypes Sabrina S. Batah, Maíra N. Benatti, Li Siyuan, Wagner M. Telini, Jamile O. Barboza, Marcelo B. Menezes, et al. (+27)
51 [GO] 2022―Jan―25 Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes Laia Reverté, Elena Yeregui, Montserrat Olona, Alicia Gutiérrez-Valencia, Maria José Buzón, Anna Martí, et al. (+13)
52 [GO] 2021―Dec―28 The volatile and heterogeneous gut microbiota shifts of COVID-19 patients over the course of a probiotics-assisted therapy Chunyan Wu, Qian Xu, Zhan Cao, Dengdeng Pan, Ying Zhu, Sheng Wang, et al. (+8)
53 [GO] 2021―Dec―19 Correlation of vaccine-elicited antibody levels and neutralizing activities against SARS-CoV-2 and its variants Jinbiao Liu, Brittany H Bodnar, Nigam H Padhiar, Adil I Khan, Fengzhen Meng, Sami Saribas, et al. (+8)
54 [GO] 2021―Dec―15 ACEs family genes: Important molecular links between lung cancer and COVID-19 Yinjiang Zhang, Lu Fan, Rongfei Yao, Xu He, Linyi Zhao, Binan Lu, Zongran Pang
55 [GO] 2021―Dec―15 The omicron variant of SARS-CoV-2: Understanding the known and living with unknowns Nicholas E. Ingraham, David H. Ingbar
56 [GO] 2021―Dec―13 How to translate the knowledge of COVID-19 into the prevention of Omicron variants Xiangdong Wang, Charles A. Powell
57 [GO] 2021―Nov―04 The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID-19 Mingfeng Liao, Xuejiao Liao, Jing Yuan, Bing Zhou, Yang Liu, Xiao Jiang, et al. (+6)
58 [GO] 2021―Nov―04 SARS-CoV-2 infection in lung transplant recipients induces circulating exosomes with SARS-CoV-2 spike protein S2 Sandhya Bansal, Sofya Tokman, Timothy Fleming, Gabriel N. Maine, Kristina Sanborn, Ramsey Hachem, et al. (+4)
59 [GO] 2021―Oct―21 The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós, Verónica Terrón, Charbel Maroun-Eid, Karla Montalbán-Hernández, et al. (+14)
60 [GO] 2021―Sep―27 Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID-19 Zhaoming Zhou, Xiang Zhou, Liming Cheng, Lei Wen, Taixue An, Heng Gao, et al. (+22)
61 [GO] 2021―Sep―27 SARS-CoV-2 spike protein alleviates atherosclerosis by suppressing macrophage lipid uptake through regulating R-loop formation on MSR1 mRNA Wenting Zhao, Zhen Wang, Wenjing Chen, Miao Chen, Jie Han, Xiang Yin, et al. (+4)
62 [GO] 2021―Sep―21 Host transcriptional response to SARS-CoV-2 infection in COVID-19 patients Nitesh Kumar Singh, Surabhi Srivastava, Lamuk Zaveri, Thrilok Chander Bingi, Rajarao Mesipogu, Santosh Kumar V., et al. (+10)
63 [GO] 2021―May―22 Identification of potential vaccine targets for COVID-19 by combining single-cell and bulk TCR sequencing Pingping Wang, Zhaochun Xu, Wenyang Zhou, Xiyun Jin, Chang Xu, Meng Luo, et al. (+7)
64 [GO] 2021―May―22 Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children Yue Tao, Ruwen Yang, Chen Wen, Jue Fan, Jing Ma, Qiao He, et al. (+9)
65 [GO] 2021―Apr―04 Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19 Rita Valenzuela, Maria A. Pedrosa, Pablo Garrido-Gil, Carmen M. Labandeira, Gemma Navarro, Rafael Franco, et al. (+2)
66 [GO] 2021―Mar―24 Distinct kinetics of immunoglobulin isotypes reveal early diagnosis and disease severity of COVID-19: A 6-month follow-up Siyang Yu, Jianghong An, Xuejiao Liao, Haiyan Wang, Fen Ma, Dapeng Li, et al. (+9)
67 [GO] 2021―Mar―01 Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study Francesco Vieceli Dalla Sega, Francesca Fortini, Savino Spadaro, Luca Ronzoni, Ottavio Zucchetti, Marco Manfrini, et al. (+13)
68 [GO] 2021―Feb―26 Accurate classification of COVID-19 patients with different severity via machine learning Chaoyang Sun, Yong Bai, Dongsheng Chen, Liang He, Jiacheng Zhu, Xiangning Ding, et al. (+5)
69 [GO] 2021―Feb―23 SARS-CoV-2-related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan-cancers Xue-Ping Li, Xin Huang, Yan-Mei Qin, Guo-Yan Wu, Cheng-Cai Liang, Yu-Jun Dai, Wei-Na Zhang
70 [GO] 2021―Feb―18 Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection Wei Xu, Shan Su, Shibo Jiang
71 [GO] 2021―Jan―27 Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial Xiaowei Xu, Wanli Jiang, Lijun Chen, Zhenyu Xu, Qiang Zhang, Mengfei Zhu, et al. (+23)
72 [GO] 2021―Jan―17 Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein Satish Sagar, Ashok Kumar Rathinavel, William E. Lutz, Lucas R. Struble, Surender Khurana, Andy T. Schnaubelt, et al. (+9)
73 [GO] 2021―Jan―15 Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics Shan Su, Qian Wang, Shibo Jiang
74 [GO] 2021―Jan―02 Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID-19 outcomes María P. Fernández-Pérez, Sonia Águila, Laura Reguilón-Gallego, Ascensión M. los Reyes-García, Antonia Miñano, Carlos Bravo-Pérez, et al. (+10)
75 [GO] 2020―Dec―22 Clinical efficacy of convalescent plasma therapy on treating COVID-19 patients: Evidence from matched study and a meta-analysis Weijun Jiang, Weiwei Li, Lei Xiong, Qiuyue Wu, Jian Wu, Bangshun He, et al. (+9)
76 [GO] 2020―Dec―10 A real-world study of glucocorticoid treatment in COVID-19 patients with different disease severities Xiaofei Jiao, Ya Wang, Dan Liu, Shaoqing Zeng, Jianhua Chi, Ruyuan Li, et al. (+8)
77 [GO] 2020―Nov―08 Buffer wards for the control of COVID-19 transmission in hospitals Wensi Zhao, Yi Gao, Qiuni Xu, Wanjun Ding, Dedong Cao, Zhuya Xiao, et al. (+7)
78 [GO] 2020―Nov―03 Persistent viral activity, cytokine storm, and lung fibrosis in a case of severe COVID-19 Gang Xu, Yang Liu, Mingfeng Liao, Jizhou Gou, Xin Wang, Jing Yuan, et al. (+5)
79 [GO] 2020―Oct―21 CIRPMC: An online model with simplified inflammatory signature to predict the occurrence of critical illness in patients with COVID-19 Yue Gao, Lingxi Chen, Shaoqing Zeng, Xikang Feng, JianHua Chi, Ya Wang, et al. (+20)
80 [GO] 2020―Oct―18 Instantaneous “catch-and-kill” inactivation of SARS-CoV-2 by nitride ceramics Giuseppe Pezzotti, Eriko Ohgitani, Masaharu Shin-Ya, Tetsuya Adachi, Elia Marin, Francesco Boschetto, et al. (+2)
81 [GO] 2020―Oct―14 Immunological strategies against spike protein: Neutralizing antibodies and vaccine development for COVID-19 Jiansheng Huang, Hui Huang, Dongdong Wang, Chuan Wang, Youfa Wang
82 [GO] 2020―Oct―11 The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19 Hao Tang, Yuehan Gao, Zhaohuai Li, Yushan Miao, Zhaohao Huang, Xiuxing Liu, et al. (+5)
83 [GO] 2020―Sep―16 Immunity-modulated sex disparity on COVID-19 prognosis Dan Liu, Jiahao Liu, Shaoqing Zeng, Ya Wang, Yuan Yuan, Sen Xu, et al. (+9)
84 [GO] 2020―Aug―22 COVID-19 diagnostic testing: Technology perspective Meng Xu, Dan Wang, Hongye Wang, Xiaomei Zhang, Te Liang, Jiayu Dai, et al. (+5)
85 [GO] 2020―Jul―22 Alteration of serum markers in COVID-19 and implications on mortality Dan Liu, Ruyuan Li, Ruidi Yu, Ya Wang, Xinxia Feng, Yuan Yuan, et al. (+21)
86 [GO] 2020―Jun―11 Mental health and psychosocial function of general population during the COVID-19 epidemic in China Qi Zhou, Zhenyu Hu, Guolin Bian, Haihang Yu, Xingxing Li, Yin Lu, et al. (+6)
87 [GO] 2020―Jun―09 Acute lung injury in patients with COVID-19 infection Liyang Li, Qihong Huang, Diane C. Wang, David H. Ingbar, Xiangdong Wang
88 [GO] 2020―Jun―09 Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports Linlin Zhang, Diane C. Wang, Qihong Huang, Xiangdong Wang
89 [GO] 2020―Jun―09 Collaborated effort against SARS-CoV-2 outbreak in China Qiwen Yang, Yang Zhou, Jingwen Ai, Jinmin Ma, Fenglin Cao, Weifan Cao, et al. (+6)
90 [GO] 2020―Jun―09 Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia? Yunbao Pan, Guangming Ye, Xiantao Zeng, Guohong Liu, Xiaojiao Zeng, Xianghu Jiang, et al. (+8)
91 [GO] 2020―Jun―08 A new and rapid approach for detecting COVID-19 based on S1 protein fragments Hua Li, Zhe Liu, Yue He, Yingjie Qi, Jie Chen, Yuanyuan Ma, et al. (+6)
92 [GO] 2020―Jun―08 COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis Hooman D. Poor, Corey E. Ventetuolo, Thomas Tolbert, Glen Chun, Gregory Serrao, Amanda Zeidman, et al. (+4)
93 [GO] 2020―Jun―08 Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China Fuyang Chen, Wenwu Sun, Shengrong Sun, Zhiyu Li, Zhong Wang, Li Yu
94 [GO] 2020―Jun―08 Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients Zibo Meng, Dianyun Ren, Yun Liu, Xiaoming Lu, Wei Xiong, Xin Jin
95 [GO] 2020―Jun―08 Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China Chaomin Wu, Xianglin Hu, Jianxin Song, Dong Yang, Jie Xu, Kebin Cheng, et al. (+16)
96 [GO] 2020―Jun―08 Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019 Chengshui Chen, Feng Qi, Keqing Shi, Yuping Li, Ji Li, Yongping Chen, et al. (+7)
97 [GO] 2020―Feb―20 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies Jun She, Jinjun Jiang, Ling Ye, Lijuan Hu, Chunxue Bai, Yuanlin Song

97 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec